The NIH spent $100B+ on research behind every FDA-approved drug from 2010–2016—yet taxpayers get no return. Pharma profits off public risk. We need revenue-sharing, price protections, or a public option. Taxpayers shouldn’t pay twice. #PublicReturnOnPublicInvestment #PharmaReform
0
0
0
0